Cancer
AI Tool Enhances Accuracy in Predicting Patient Response to Cancer Immunotherapy Drugs
In the relentless pursuit of personalized cancer treatment, a groundbreaking artificial intelligence (AI) model named COMPASS is setting a new...
Apelin-APLNR Pathway: Endothelial Roles in Health
The Apelin–APLNR Signaling Axis: A Novel Guardian of Lung Health and Inflammation In recent years, the Apelin–APLNR pathway has emerged...
Three Clinical Scholars Join Ludwig Institute for Cancer Research
On July 1, 2026, a significant advancement was announced in the realm of clinical cancer research with the appointment of...
Validating 18F-THK5351 for Imaging Astrogliosis
In a groundbreaking study published recently, researchers unveiled a meticulous validation of the positron emission tomography (PET) tracer ^18F-THK5351, a...
Next-Generation HIF-2α Inhibitor Demonstrates Potential in Translational Clinical Trial for Kidney Cancer
In a groundbreaking advancement for kidney cancer therapeutics, researchers at the Dana-Farber Cancer Institute have pioneered the first-in-patient clinical trial...
Rethinking the Label: Could Dropping the ‘Cancer’ Tag from Lowest-Risk Prostate Cases Save Lives?
In a groundbreaking shift poised to redefine prostate cancer diagnosis and treatment, a team led by researchers at UCLA has...
Cancer-Linked Extracellular Vesicles Impact Systemic Health
Cancer, traditionally viewed as a localized disease, has increasingly been understood as a systemic disorder that fundamentally disrupts the homeostasis...
Breakthrough Immunotherapy Offers Hope in Combatting Fatal Brain Tumors
A groundbreaking study spearheaded by a leading researcher affiliated with King’s College London and McMaster University in Canada unveils a...
McMaster Researchers Develop Immunotherapy Targeting Aggressive Brain Tumors and Their Energy Source
In a groundbreaking advancement in the battle against one of the most formidable brain cancers, researchers at McMaster University have...
Mapping Cancer-Fighting Antibodies in Human Tumors with Unmatched Precision
A Revolutionary Lens Into the Tumor Microenvironment: Mapping Antibody Distribution at Single-Cell Resolution The fight against cancer has seen remarkable...
Common Brain Cancer Mutation Alters DNA Structure to Promote Progression, Revealing New Therapeutic Target
In a groundbreaking study published in Nucleic Acids Research, scientists at The University of Texas MD Anderson Cancer Center have...
Exercise-Trigged Cilia Boost Bone Growth
In a groundbreaking study that bridges cellular biology and exercise physiology, researchers have unlocked a molecular mechanism that elucidates how...
Dana-Farber Researchers Unveil Promising Phase 2 Results for Targeted Therapy in Rare Bile Duct Cancer
A Breakthrough in Targeted Therapy: Zenocutuzumab Offers Hope for Patients with Rare NRG1-Positive Cholangiocarcinoma Cholangiocarcinoma, a rare but aggressive malignancy...
CAR T Cell Therapy Targets Crucial Mutation Behind Rare Blood Cancers
A groundbreaking advancement in cancer immunotherapy has emerged from collaborative research led by scientists at University College London (UCL) and...
New Study Reveals How “Junk DNA” Fuels Cancer Growth
In recent years, the concept of “junk DNA” has undergone a dramatic transformation in the field of cancer biology, shifting...
Gustave Roussy and The Lancet Introduce Pioneering International Oncology Lecture Series
In a significant leap for the oncology research community, Gustave Roussy, Europe’s preeminent comprehensive cancer center, has joined forces with...
Intranasal NAD Restores Olfactory Dysfunction
In a groundbreaking advancement poised to revolutionize the treatment of olfactory dysfunction, a team of researchers has unveiled a novel...
Cancer Mortality Post-Organ Transplant: EpCOT Study
In a groundbreaking study published in the British Journal of Cancer, researchers have unveiled critical insights into cancer-related mortality following...
Metabolic Reprogramming in Myeloid Cells: AI Therapies
In the rapidly evolving landscape of cancer research, the metabolic reprogramming of myeloid cells has emerged as a pivotal area...
Scientists Discover ‘Mix and Match’ Strategy to Develop Novel Cancer-Fighting Drugs
In a remarkable breakthrough poised to redefine cancer drug development, scientists at the University of Warwick and Monash University have...
